Empowered Funds LLC Makes New Investment in Agilent Technologies, Inc. $A

Empowered Funds LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, HoldingsChannel reports. The fund purchased 45,202 shares of the medical research company’s stock, valued at approximately $6,004,000.

A number of other large investors have also modified their holdings of A. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after buying an additional 24,687 shares during the period. Bank of Nova Scotia acquired a new stake in Agilent Technologies in the second quarter valued at approximately $58,539,000. Dudley & Shanley Inc. lifted its stake in Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock worth $9,232,000 after acquiring an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new position in Agilent Technologies in the second quarter worth approximately $834,000. Finally, Crossmark Global Holdings Inc. grew its holdings in Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after acquiring an additional 9,615 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. TD Cowen increased their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday. Citigroup lifted their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Morgan Stanley increased their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Finally, Royal Bank Of Canada raised their price target on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $154.47 on Monday. The firm has a market capitalization of $43.63 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.34 and a beta of 1.25. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $163.75. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The firm’s 50 day moving average is $140.30 and its two-hundred day moving average is $127.04.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter last year, the company earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.